Wednesday, 30 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q3 FY26

Brawn Biotech Q3 FY26 Results: Net Profit ₹0 Cr

Brawn Biotech Ltd reported net profit of ₹0 Cr for Q3 FY26.

Q3 FY26 at a glance · ₹ crore
MetricQ3 FY26Q2 FY26Q3 FY25
Other income0.10.10.0
Total income4.45.03.8
Net profit0.00.1-0.4
Operating margin0.0%2.0%-10.5%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Source

BSE results filing, NSE: BRAWN. Figures extracted from the filing.

Read the filing ↗

Brawn Biotech Ltd: key numbers

Share price
₹22.45
Market cap
₹6.74 Cr
Revenue (annual)
₹16.98 Cr
Net profit (annual)
₹0.94 Cr
P/E (TTM)
7.8×Sector 49.8×
Promoter holding
52.94%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Brawn Biotech Ltd

All →
16:46 IST BSE
Other Announcement

Brawn Biotech Other Announcement

Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.

16:45 IST BSE
Annual General Meeting

Brawn Biotech Annual General Meeting

Brawn Biotech Ltd has filed the notice for its 41st Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.

16:57 IST BSE
Board Meeting Date

Brawn Biotech Board Meeting Date

Brawn Biotech Ltd has scheduled a Board Meeting for August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

16:20 IST BSE
Other Announcement

Brawn Biotech Other Announcement

Brawn Biotech Ltd notified BSE regarding the non-applicability of Regulation 24A for Annual Secretarial Compliance Report. The company remains below the mandatory reporting thresholds for capital and networth.